Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 13161.43 | 1445 / 1445 | 100% | 319.39 | 183 / 183 |
ovary | 100% | 20611.88 | 180 / 180 | 100% | 343.33 | 430 / 430 |
pancreas | 100% | 10824.59 | 328 / 328 | 100% | 196.58 | 178 / 178 |
skin | 100% | 15450.70 | 1809 / 1809 | 100% | 324.18 | 471 / 472 |
uterus | 100% | 18527.59 | 170 / 170 | 100% | 380.28 | 458 / 459 |
thymus | 100% | 13715.79 | 653 / 653 | 100% | 253.02 | 603 / 605 |
stomach | 100% | 11449.58 | 359 / 359 | 100% | 307.30 | 285 / 286 |
intestine | 100% | 14669.36 | 966 / 966 | 99% | 323.84 | 524 / 527 |
prostate | 100% | 14181.20 | 245 / 245 | 99% | 239.92 | 499 / 502 |
breast | 100% | 11669.43 | 459 / 459 | 99% | 283.67 | 1109 / 1118 |
lung | 100% | 11587.91 | 577 / 578 | 99% | 265.00 | 1142 / 1155 |
bladder | 100% | 15290.33 | 21 / 21 | 99% | 328.84 | 497 / 504 |
brain | 99% | 7185.22 | 2608 / 2642 | 100% | 209.83 | 704 / 705 |
adrenal gland | 100% | 10917.49 | 258 / 258 | 98% | 156.22 | 225 / 230 |
kidney | 100% | 10332.20 | 89 / 89 | 97% | 128.47 | 878 / 901 |
liver | 100% | 5605.57 | 226 / 226 | 95% | 135.41 | 385 / 406 |
adipose | 100% | 10505.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 380.11 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 386.79 | 29 / 29 |
muscle | 100% | 10362.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 14796.65 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 352.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 181.96 | 1 / 1 |
blood vessel | 100% | 12491.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 6932.18 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 9622.12 | 894 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO_0016925 | Biological process | protein sumoylation |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_0006281 | Biological process | DNA repair |
GO_0060028 | Biological process | convergent extension involved in axis elongation |
GO_0045087 | Biological process | innate immune response |
GO_0045739 | Biological process | positive regulation of DNA repair |
GO_0060669 | Biological process | embryonic placenta morphogenesis |
GO_0090309 | Biological process | positive regulation of DNA methylation-dependent heterochromatin formation |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0071514 | Biological process | genomic imprinting |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0044790 | Biological process | suppression of viral release by host |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0007566 | Biological process | embryo implantation |
GO_0000792 | Cellular component | heterochromatin |
GO_0000791 | Cellular component | euchromatin |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0019789 | Molecular function | SUMO transferase activity |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0070087 | Molecular function | chromo shadow domain binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0035851 | Molecular function | Krueppel-associated box domain binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TRIM28 |
Protein name | Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28) Tripartite motif containing 28 |
Synonyms | TIF1B RNF96 KAP1 |
Description | FUNCTION: Nuclear corepressor for KRAB domain-containing zinc finger proteins (KRAB-ZFPs). Mediates gene silencing by recruiting CHD3, a subunit of the nucleosome remodeling and deacetylation (NuRD) complex, and SETDB1 (which specifically methylates histone H3 at 'Lys-9' (H3K9me)) to the promoter regions of KRAB target genes. Enhances transcriptional repression by coordinating the increase in H3K9me, the decrease in histone H3 'Lys-9 and 'Lys-14' acetylation (H3K9ac and H3K14ac, respectively) and the disposition of HP1 proteins to silence gene expression. Recruitment of SETDB1 induces heterochromatinization. May play a role as a coactivator for CEBPB and NR3C1 in the transcriptional activation of ORM1. Also a corepressor for ERBB4. Inhibits E2F1 activity by stimulating E2F1-HDAC1 complex formation and inhibiting E2F1 acetylation. May serve as a partial backup to prevent E2F1-mediated apoptosis in the absence of RB1. Important regulator of CDKN1A/p21(CIP1). Has E3 SUMO-protein ligase activity toward itself via its PHD-type zinc finger. Also specifically sumoylates IRF7, thereby inhibiting its transactivation activity. Ubiquitinates p53/TP53 leading to its proteasomal degradation; the function is enhanced by MAGEC2 and MAGEA2, and possibly MAGEA3 and MAGEA6. Mediates the nuclear localization of KOX1, ZNF268 and ZNF300 transcription factors. In association with isoform 2 of ZFP90, is required for the transcriptional repressor activity of FOXP3 and the suppressive function of regulatory T-cells (Treg) . Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells . Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) . In ESCs, in collaboration with SETDB1, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (By similarity). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing . The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions . .; FUNCTION: (Microbial infection) Plays a critical role in the shutdown of lytic gene expression during the early stage of herpes virus 8 primary infection. This inhibition is mediated through interaction with herpes virus 8 protein LANA1. . |
Accessions | ENST00000597968.1 ENST00000341753.10 [Q13263-2] ENST00000597136.1 M0R0K9 M0R2I3 ENST00000593582.5 M0R3C0 ENST00000253024.10 [Q13263-1] Q13263 ENST00000594806.5 M0QZE6 |